Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

RPRX

Royalty Pharma plc

Sep 17 • 04:00PM ET

28.24

Dollar change -0.02
Percentage change -0.07	%

Healthcare • Biotechnology • USA • NASD

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: VTI VO VXF VTV VOE VYM VHT IWR IHE IWD

Scroll to Statements

Index	-	P/E	18.79	EPS (ttm)	1.50	Insider Own	14.69%	Shs Outstand	446.69M	Perf Week	0.64%
Market Cap	12.66B	Forward P/E	6.43	EPS next Y	4.39	Insider Trans	0.00%	Shs Float	382.30M	Perf Month	3.94%
Income	672.90M	PEG	5.87	EPS next Q	0.92	Inst Own	70.74%	Short Float	3.84%	Perf Quarter	6.13%
Sales	2.24B	P/S	5.66	EPS this Y	-11.85%	Inst Trans	1.54%	Short Ratio	5.51	Perf Half Y	-6.02%
Book/sh	14.42	P/B	1.96	EPS next Y	11.17%	ROA	3.88%	Short Interest	14.68M	Perf Year	0.39%
Cash/sh	4.02	P/C	7.02	EPS next 5Y	3.20%	ROE	10.56%	52W Range	25.20 - 31.66	Perf YTD	0.53%
Dividend Est.	0.92 (3.25%)	P/FCF	4.71	EPS past 5Y	2.23%	ROI	4.78%	52W High	-10.79%	Beta	0.46
Dividend TTM	0.83 (2.94%)	Quick Ratio	9.35	Sales past 5Y	5.78%	Gross Margin	-	52W Low	12.06%	ATR (14)	0.52
Dividend Ex-Date	Aug 16, 2024	Current Ratio	9.35	EPS Y/Y TTM	165.78%	Oper. Margin	42.92%	RSI (14)	52.35	Volatility	1.55% 1.60%
Employees	89	Debt/Eq	1.17	Sales Y/Y TTM	-5.25%	Profit Margin	30.07%	Recom	1.33	Target Price	44.43
Option/Short	Yes / Yes	LT Debt/Eq	1.17	EPS Q/Q	-55.20%	Payout	31.57%	Rel Volume	0.57	Prev Close	28.26
Sales Surprise	-3.10%	EPS Surprise	-0.39%	Sales Q/Q	-0.17%	Earnings	Aug 08 BMO	Avg Volume	2.67M	Price	28.24
SMA20	-0.14%	SMA50	1.63%	SMA200	-0.08%	Trades		Volume	1,526,117	Change	-0.07%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-03-24	Downgrade	UBS	Buy → Neutral	$28
Jun-14-22	Resumed	UBS	Buy	$47
May-13-22	Initiated	Scotiabank	Sector Outperform	$53
Apr-27-22	Initiated	Goldman	Buy	$56
Apr-14-22	Upgrade	JP Morgan	Neutral → Overweight	$50
Apr-06-22	Resumed	Morgan Stanley	Overweight	$48
Oct-29-21	Upgrade	Citigroup	Neutral → Buy	$50
Jul-30-21	Initiated	Tigress Financial	Buy	$50
Nov-09-20	Upgrade	UBS	Neutral → Buy	$52 → $51
Jul-14-20	Initiated	Evercore ISI	In-line
Jul-13-20	Initiated	UBS	Neutral	$52
Jul-13-20	Initiated	SunTrust	Buy	$56
Jul-13-20	Initiated	Morgan Stanley	Equal-Weight	$51
Jul-13-20	Initiated	JP Morgan	Neutral	$50
Jul-13-20	Initiated	Goldman	Neutral	$47
Jul-13-20	Initiated	Cowen	Outperform	$55
Jul-13-20	Initiated	Citigroup	Neutral	$50
Jul-13-20	Initiated	BofA Securities	Buy	$55

Show Previous Ratings

Sep-03-24 05:14PM	Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement (GlobeNewswire)
05:06PM	Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement (GlobeNewswire)
Aug-28-24 04:15PM	Royalty Pharma to Present at Morgan Stanley's 22nd Annual Global Healthcare Conference (GlobeNewswire)
Aug-26-24 06:16AM	Jim Cramer on Royalty Pharma plc (NASDAQ:RPRX): Its Been a Bit of a Bust, I Feel Badly (Insider Monkey)
Aug-23-24 05:32AM	Jim Cramer's Latest Lightning Round: Top 10 Stocks (Insider Monkey)
03:58PM	Loading…
Aug-17-24 03:58PM	Why Is Royalty Pharma plc (RPRX) the Best Defensive Stock to Buy Now? (Insider Monkey)
Aug-16-24 06:09PM	10 Best Defensive Stocks To Buy Now (Insider Monkey)
Aug-09-24 01:05AM	Royalty Pharma PLC (RPRX): A Strategic SWOT Insight (GuruFocus.com)
Aug-08-24 04:16PM	Analyst Report: Royalty Pharma plc (Morningstar Research)
07:00AM	Royalty Pharma Reports Second Quarter 2024 Results (GlobeNewswire)
Jul-24-24 08:30AM	Royalty Pharma Appoints Molly Sawaya as Executive Vice President, Head of Human Capital (GlobeNewswire)
Jul-19-24 08:15AM	Royalty Pharma to Announce Second Quarter 2024 Financial Results on August 8, 2024 (GlobeNewswire)
Jul-17-24 04:15PM	Royalty Pharma Declares Third Quarter 2024 Dividend (GlobeNewswire)
Jul-15-24 12:10PM	Will Royalty Pharma (RPRX) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Jul-02-24 07:44PM	Is Royalty Pharma plc (RPRX) a Good Stock to Buy Now? (Insider Monkey)
06:58PM	Loading…
06:58PM	10 Best Undervalued Stocks To Buy Now (Insider Monkey)
Jun-26-24 06:00AM	Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for June 2024 (InvestorPlace)
Jun-24-24 12:56PM	7 Biotech Stocks to Buy on the Dip: June 2024 (InvestorPlace)
Jun-05-24 06:14AM	June's Biotech Boom: 3 Stocks to Buy for a Summertime Surge (InvestorPlace)
Jun-04-24 04:15PM	Royalty Pharma to Present at the Goldman Sachs 45th Annual Global Healthcare Conference (GlobeNewswire)
Jun-03-24 05:15PM	Royalty Pharma Announces Pricing of $1.5 Billion of Senior Unsecured Notes (GlobeNewswire)
May-28-24 07:10AM	Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 Million (GlobeNewswire)
May-27-24 06:28PM	Is Cytokinetics, Incorporated (NASDAQ:CYTK) the Best Mid-Cap Healthcare Stock To Buy Now? (Insider Monkey)
May-25-24 11:10PM	20 Biggest Publicly Traded Biotech Companies (Insider Monkey)
May-22-24 04:10PM	Royalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline (GlobeNewswire)
04:00PM	Cytokinetics and Royalty Pharma Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline (GlobeNewswire)
May-20-24 02:41PM	7 Dividend Stocks to Buy at a 52-Week Low (InvestorPlace)
May-13-24 08:15AM	Royalty Pharma to Present at Upcoming Investor Conferences (GlobeNewswire)
May-10-24 01:07AM	Royalty Pharma PLC (RPRX): A Strategic SWOT Insight (GuruFocus.com)
May-09-24 03:35PM	Analyst Report: Royalty Pharma plc (Morningstar Research)
12:00PM	Loading…
12:00PM	Royalty Pharma (RPRX) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
11:56AM	RPRX Stock Earnings: Royalty Pharma Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
10:46AM	Cytokinetics, Incorporated (NASDAQ:CYTK) Q1 2024 Earnings Call Transcript (Insider Monkey)
08:10AM	Royalty Pharma (RPRX) Beats Q1 Earnings and Revenue Estimates (Zacks)
07:00AM	Royalty Pharma Reports First Quarter 2024 Results (GlobeNewswire)
06:45AM	Royalty Pharma to Acquire Royalty Interest in Sanofi's Frexalimab (GlobeNewswire)
May-08-24 08:51AM	Why Earnings Season Could Be Great for Royalty Pharma (RPRX) (Zacks)
May-06-24 09:16AM	Insights Into Royalty Pharma (RPRX) Q1: Wall Street Projections for Key Metrics (Zacks)
May-02-24 04:01PM	Arrowhead Pharmaceuticals Earns $50 Million Milestone from Royalty Pharma (Business Wire)
10:01AM	Royalty Pharma (RPRX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release (Zacks)
Apr-30-24 08:37AM	PureTech Health plc (NASDAQ:PRTC) Q4 2023 Earnings Call Transcript (Insider Monkey)
Apr-19-24 08:15AM	Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024 (GlobeNewswire)
Apr-17-24 08:15AM	Royalty Pharma Declares Second Quarter 2024 Dividend (GlobeNewswire)
Mar-17-24 08:50AM	30 Biggest Biotechnology Companies in the World (Insider Monkey)
Feb-28-24 04:15PM	Royalty Pharma to Present at TD Cowen's 44th Annual Health Care Conference (GlobeNewswire)
Feb-20-24 12:45PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
Feb-17-24 12:15AM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
Feb-16-24 03:30PM	Royalty Pharma (RPRX) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
09:45AM	Royalty Pharma plc (NASDAQ:RPRX) Q4 2023 Earnings Call Transcript (Insider Monkey)
12:04AM	Royalty Pharma PLC (RPRX): A Strategic SWOT Insight (GuruFocus.com)
Feb-15-24 11:08PM	Analyst Report: Royalty Pharma plc (Morningstar Research)
07:58AM	Royalty Pharma PLC (RPRX) Earnings Report: A Detailed Analysis (GuruFocus.com)
07:30AM	Royalty Pharma Reports Q4 and Full Year 2023 Results (GlobeNewswire)
Jan-31-24 01:04AM	What Makes Royalty Pharma plc (RPRX) a Compelling Stock? (Insider Monkey)
Jan-30-24 04:15PM	Royalty Pharma To Announce Fourth Quarter And Full Year 2023 Financial Results On February 15, 2024 (GlobeNewswire)
Jan-19-24 08:15AM	Royalty Pharma Announces Dividend Increase (GlobeNewswire)
Jan-08-24 07:00AM	Royalty Pharma Highlights Accomplishments and Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-18-23 05:30AM	Should You Sell Royalty Pharma plc (RPRX)? (Insider Monkey)
Nov-27-23 04:15PM	Royalty Pharma to Present at the Evercore ISI 6th Annual HealthCONx Conference (GlobeNewswire)
Nov-13-23 08:10AM	Royalty Pharma and Teva Collaborate to Further Accelerate Olanzapine Lai Program (GlobeNewswire)
08:00AM	Teva and Royalty Pharma Collaborate to Further Accelerate Olanzapine LAI Program (Business Wire)
Nov-09-23 04:33PM	Royalty Pharma plc (NASDAQ:RPRX) Q3 2023 Earnings Call Transcript (Insider Monkey)
12:15AM	The Royalty Pharma PLC (RPRX) Company: A Short SWOT Analysis (GuruFocus.com)
Nov-08-23 07:00AM	Royalty Pharma Reports Third Quarter 2023 Results (GlobeNewswire)
Oct-19-23 07:59AM	Royalty Pharma Announces Agreement to Purchase Up to $1.5 Billion of PTC Therapeutics' Royalty on Evrysdi (GlobeNewswire)
Oct-16-23 04:15PM	Royalty Pharma Declares Fourth Quarter 2023 Dividend (GlobeNewswire)
Oct-11-23 04:15PM	Royalty Pharma To Announce Third Quarter 2023 Financial Results On November 8, 2023 (GlobeNewswire)
Sep-21-23 08:25AM	Royalty Pharma Appoints Eric Schneider as Chief Technology Officer (GlobeNewswire)
Sep-05-23 04:15PM	Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement (GlobeNewswire)
04:01PM	Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement (GlobeNewswire)
08:25AM	Royalty Pharma to Present at Upcoming Investor Conferences (GlobeNewswire)
Aug-24-23 06:30AM	Royalty Pharma and Ferring Pharmaceuticals Enter Into US $500 Million Royalty Agreement for New Intravesical Gene Therapy Adstiladrin® (Nadofaragene Firadenovec-Vncg) (GlobeNewswire)
Aug-08-23 07:00AM	Royalty Pharma Reports Second Quarter 2023 Results (GlobeNewswire)
Jul-18-23 04:15PM	Royalty Pharma to Announce Second Quarter 2023 Financial Results on August 8, 2023 (GlobeNewswire)
Jul-17-23 04:15PM	Royalty Pharma Declares Third Quarter 2023 Dividend (GlobeNewswire)
Jun-18-23 08:58AM	Institutional owners may consider drastic measures as Royalty Pharma plc's (NASDAQ:RPRX) recent US$453m drop adds to long-term losses (Simply Wall St.)
Jun-07-23 08:15AM	Royalty Pharma to Present at the Goldman Sachs 44th Annual Global Healthcare Conference (GlobeNewswire)
May-22-23 07:52PM	Goldman Sachs Likes These 2 Stocks, Insiders Just Poured Millions Into Them Heres Why You Might Want to Ride Their Coattails (TipRanks)
May-13-23 08:15AM	Here's Why We're Wary Of Buying Royalty Pharma's (NASDAQ:RPRX) For Its Upcoming Dividend (Simply Wall St.)
May-11-23 10:42AM	Royalty Pharma's (NASDAQ:RPRX) Upcoming Dividend Will Be Larger Than Last Year's (Simply Wall St.)
May-09-23 07:00AM	Royalty Pharma Reports First Quarter 2023 Results (GlobeNewswire)
May-03-23 04:15PM	Royalty Pharma To Present At The BofA Securities 2023 Health Care Conference (GlobeNewswire)
Apr-20-23 06:15AM	Royalty Pharma (NASDAQ:RPRX) Is Increasing Its Dividend To $0.20 (Simply Wall St.)
Apr-17-23 08:15AM	Royalty Pharma Declares Second Quarter 2023 Dividend (GlobeNewswire)
Apr-13-23 09:01AM	Royalty Pharma to Announce First Quarter 2023 Financial Results on May 9, 2023 (GlobeNewswire)
Apr-05-23 06:17AM	Is Royalty Pharma plc's (NASDAQ:RPRX) Recent Price Movement Underpinned By Its Weak Fundamentals? (Simply Wall St.)
Mar-31-23 06:36AM	Daily Vickers Top Buyers & Sellers for 03/31/2023 (Argus Research)
Mar-27-23 07:30AM	Royalty Pharma Announces $1.0 Billion Share Repurchase Program (GlobeNewswire) +5.53%
Mar-23-23 07:00AM	Royalty Pharma and PureTech Health Enter Into KarXT Royalty Agreement for Up to $500 Million (GlobeNewswire)
03:00AM	PureTech Health and Royalty Pharma Enter into KarXT Royalty Agreement for up to $500 Million (Business Wire)
Mar-15-23 08:00AM	Royalty Pharma Raises Full Year 2023 Guidance (GlobeNewswire)
Mar-08-23 05:16AM	Optimism around Royalty Pharma (NASDAQ:RPRX) delivering new earnings growth may be shrinking as stock declines 3.5% this past week (Simply Wall St.)
Mar-01-23 08:15AM	Royalty Pharma Appoints Ashwin Pai as Executive Vice President, Investments (GlobeNewswire)
Feb-15-23 07:00AM	Royalty Pharma Reports Q4 and Full Year 2022 Results (GlobeNewswire)
Feb-09-23 04:15PM	Royalty Pharma to Present at Upcoming Investor Conferences (GlobeNewswire)
Feb-03-23 09:19AM	Royalty Pharma's (NASDAQ:RPRX) Dividend Will Be Increased To $0.20 (Simply Wall St.)
Jan-18-23 08:25AM	Royalty Pharma To Announce Fourth Quarter And Full Year 2022 Financial Results On February 15, 2023 (GlobeNewswire)
Jan-12-23 05:01AM	Royalty Pharma's (NASDAQ:RPRX) Shareholders Will Receive A Bigger Dividend Than Last Year (Simply Wall St.)
Jan-09-23 09:25AM	Royalty Pharma Highlights Accomplishments and Provides Business Update at 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
09:15AM	Royalty Pharma and Ionis Enter Into Royalty Agreement for Up to $1.1 Billion to Further Advance Ionis Genetic Medicines and Commercial Readiness (GlobeNewswire)

Royalty Pharma Plc provides drug development services. It operates as a funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio includes royalties, including AbbVie and J&J's Imbruvica, Astellas and Pfizer's Xtandi, Biogen's Tysabri, Gilead's HIV franchise, Merck's Januvia, Novartis' Promacta, Vertex's Kalydeco, Orkambi, Symdeko and Trikafta, and five development-stage product candidates. The company was founded by Pablo Gerardo Legorreta and Rory B. Riggs in 1996 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
RIGGS RORY B	Director	Jan 02 '24	Sale	28.52	235,200	6,707,081	254,899	Jan 04 05:16 PM
RIGGS RORY B	Director	Jan 03 '24	Sale	27.79	199,098	5,532,276	55,801	Jan 04 05:16 PM
RIGGS RORY B	Director	Jan 04 '24	Sale	27.55	35,702	983,504	20,099	Jan 04 05:16 PM
Avara Management Ltd	10% Owner	Dec 29 '23	Sale	28.04	65,803	1,845,406	2,477,520	Jan 03 04:31 PM
Avara Management Ltd	10% Owner	Dec 28 '23	Sale	28.20	209,863	5,918,934	2,543,323	Dec 29 04:29 PM
Avara Management Ltd	10% Owner	Dec 27 '23	Sale	28.01	41,729	1,168,754	2,753,186	Dec 29 04:29 PM
Avara Management Ltd	10% Owner	Dec 15 '23	Sale	28.01	10,229	286,499	2,794,915	Dec 19 04:30 PM
Avara Management Ltd	10% Owner	Dec 14 '23	Sale	28.91	364,441	10,534,276	2,805,144	Dec 15 04:31 PM
Avara Management Ltd	10% Owner	Dec 13 '23	Sale	28.95	307,935	8,916,012	3,169,585	Dec 15 04:31 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

RPRX

Royalty Pharma plc

Upgrade your FINVIZ experience